Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
At present, triple therapy is recommended by various guidelines for the treatment of
Helicobacter pylori (H.pylori) infection. Recent studies have shown increasing resistance of
H.pylori to commonly used antibiotics used in triple therapy. This study explores a
non-antibiotic treatment regime for H.pylori that uses lauric acid as the primary
anti-microbial agent. The study hypothesis is that Lauric acid works synergistically with
omeprazole following administration of a mucolytic agent to kill H.pylori topically in the
stomach.